Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Pre-Tax Income

Pre-Tax Income at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$24.26M+51.7%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$74.03M-34.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$92.31M+37.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$184M-22.7%
LQD
Liquidia CorporationLQDA
$56.78M+248%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$84.23M+18.2%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.58B+128%

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's pre-tax income?
Kiniksa Pharmaceuticals International, plc (KNSA) reported pre-tax income of $32.68M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's pre-tax income changed year-over-year?
Kiniksa Pharmaceuticals International, plc's pre-tax income increased by 110.0% year-over-year, from $15.57M to $32.68M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's pre-tax income?
Over 3 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's pre-tax income has grown at a -17.2% compound annual growth rate (CAGR), from -$156.54M to $88.87M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.